A competing risk analysis of death patterns in male genitourinary cancer

被引:1
|
作者
Bhattacharjee, Atanu [1 ]
Roy, Gaurav [2 ]
Budukh, Atul [3 ]
Dikshit, Rajesh [3 ]
Patil, Vijay M. [4 ]
Joshi, Amit [4 ]
Noronha, Vanita [4 ]
Prabash, Kumar [4 ]
Roy, Papai [5 ]
机构
[1] Tata Mem Hosp, Ctr Canc Epidemiol, Sect Biostat, Navi Mumbai, India
[2] Sir Ganga Ram Hosp, Inst Med Genet & Genom, Mol Genet Lab, New Delhi, India
[3] Tata Mem Hosp, Ctr Canc Epidemiol, Navi Mumbai, India
[4] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Mumbai, Maharashtra, India
[5] Sir Ganga Ram Hosp, Inst Med Genet & Genom, Biochem Genet Lab, New Delhi, India
关键词
competing risk; cumulative incidence; genitourinary cancer; proportional hazards; PROSTATE-CANCER; RELATIVE SURVIVAL;
D O I
10.1002/cnr2.1174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Early diagnosis and improved therapeutic options have contributed to prolonged survival in male genitourinary cancer. However, these cancer survivors may die due to other causes. Aims This work is aimed to explore the death patterns among male genitourinary cancer patients due to other causes. The occurrence of death not related to cancer is defined as competing risk (CR). Methods and results Data extracted between 1973 and 2014 for male patients (n = 638 393) diagnosed with genitourinary cancer and registered in the Surveillance, Epidemiology, and End Results (SEER) Program were included for analysis. A CR analysis was performed to explore the death patterns due to cancer or otherwise. Our study evidenced a huge proportion of patients' death due to associated factors including but not limited to cancer. Interestingly, the computed hazard ratios obtained in cancers of male organ sites such as prepuce, glans penis, penis, and spermatic cord were 1.28 (0.98-1.67), 1.53 (1.33-1.77), 1.35 (0.19-1.53), and 1.57 (1.24-2.0), respectively. However, the hazard ratios evaluated on factors other than cancer in the same organ sites were 0.95 (0.76-1.18), 1.14 (0.99-1.3), 1.09 (0.97-1.22), and 1.12 (0.86-1.46), respectively. Conclusion This study shows that among the male genitourinary cancer patients, the significant proportion of deaths occurs due to reasons unrelated to cancer. It can be concluded that the magnitude of death due to only genitourinary cancer is minimal and is not as high as documented in the earlier literature.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis
    Gayle, Alicia, V
    Minelli, Cosetta
    Quint, Jennifer K.
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [42] Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis
    Liu, Jiaqing
    Zhou, Huaqiang
    Zhang, Yaxiong
    Fang, Wenfeng
    Yang, Yunpeng
    Hong, Shaodong
    Chen, Gang
    Zhao, Shen
    Chen, Xi
    Zhang, Zhonghan
    Xian, Wei
    Shen, Jiayi
    Huang, Yan
    Zhao, Hongyun
    Zhang, Li
    FUTURE ONCOLOGY, 2019, 15 (21) : 2479 - 2488
  • [43] Cumulative incidence of death after radical prostatectomy for localized prostate cancer in Denmark 1995-2011: A competing risk analysis
    Oder, M. Andreas
    Brasso, Klaus
    Jorgen, Johansen
    Langkilde, Niels C.
    Hvarness, Helle
    Carlsson, Steen
    Jakobsen, Henrik
    Borre, Michael
    Iversion, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 9 - 10
  • [44] RISK OF GENITOURINARY MALIGNANCIES AFTER CANCER OF THE PROSTATE
    GREENBERG, RS
    RUSTIN, ED
    CLARK, WS
    CANCER, 1988, 61 (02) : 396 - 401
  • [45] The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis
    Tosco, Lorenzo
    Laenen, Annouschka
    Briganti, Alberto
    Gontero, Paolo
    Karnes, R. Jeffrey
    Bastian, Patrick J.
    Chlosta, Piotr
    Claessens, Frank
    Chun, Felix K.
    Everaerts, Wouter
    Gratzke, Christian
    Albersen, Maarten
    Graefen, Markus
    Kneitz, Burkhard
    Marchioro, Giansilvio
    Salas, Rafael Sanchez
    Tombal, Bertrand
    Van den Broeck, Thomas
    Van der Poel, Henk
    Walz, Jochen
    De Meerleer, Gert
    Bossi, Alberto
    Haustermans, Karin
    Van Poppel, Hendrik
    Spahn, Martin
    Joniau, Steven
    EUROPEAN UROLOGY FOCUS, 2018, 4 (03): : 369 - 375
  • [46] EVALUATING GERONTOLOGICAL OUTCOMES IN THE PRESENCE OF COMPETING RISK OF DEATH
    不详
    GERONTOLOGIST, 2011, 51 : 611 - 611
  • [47] Risk of second malignancies after definitive therapy for esophageal cancer: A competing risk analysis
    Mitani, S.
    Oze, I.
    Kadowaki, S.
    Masuishi, T.
    Narita, Y.
    Taniguchi, H.
    Ura, T.
    Ando, M.
    Tajika, M.
    Makita, C.
    Kodaira, T.
    Uemura, N.
    Abe, T.
    Muro, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes
    Grundmark, Birgitta
    Garmo, Hans
    Loda, Massimo
    Busch, Christer
    Holmberg, Lars
    Zethelius, Bjorn
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) : 2088 - 2096
  • [49] Prediction of Risk of Metastatic Recurrence for Female Breast Cancer Patients in the Presence of Competing Causes of Death
    Mariotto, Angela B.
    Botta, Laura
    Bernasconi, Alice
    Zou, Zhaohui
    Gatta, Gemma
    Capocaccia, Riccardo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12) : 1683 - 1689
  • [50] Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte Cancer
    Verkouteren, Joris A. C.
    Nijsten, Tamar
    Hollestein, Loes M.
    JAMA DERMATOLOGY, 2016, 152 (04) : 493 - 494